WPD Pharmaceuticals Inc.
WPD Pharmaceuticals Inc.
WPD Pharmaceuticals is a biotechnology research and development company. The Company operates in the pharmaceuticals industry with a focus on oncology, namely research and development of medicinal products involving biological compounds and small molecules. The Issuer is developing drugs which were researched at institutions including MD Anderson Cancer Center, Mayo Clinic and Emory University, and has ongoing collaborations with Wake Forest University and leading hospitals and academic centers in Poland.
WPD Pharmaceuticals Inc. (WBIO)
SEDAR Information
Company Info
Capitalization
Bulletins
2022-0708 – Suspensions (MCCN, MEAL, WBIO, TELE, GBMC, CBDN)
Le 11 juillet/July 2022
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or more securities commissions.
